Achieve Life Sciences Inc Share Price Nasdaq
Equities
US68230A1060
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | 257K 21.45M | Capitalization | 162M 13.53B |
---|---|---|---|---|---|
Net income 2024 * | -33M -2.75B | Net income 2025 * | -37M -3.09B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 631 x |
P/E ratio 2024 * |
-4.46
x | P/E ratio 2025 * |
-4.84
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.59% |
Latest transcript on Achieve Life Sciences Inc
Managers | Title | Age | Since |
---|---|---|---|
John Bencich
CEO | Chief Executive Officer | 47 | 01/14/01 |
Richard Stewart
CHM | Chairman | 65 | 01/15/01 |
Cindy Jacobs
PSD | President | 66 | 01/08/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Vaughn Himes
BRD | Director/Board Member | 63 | 14/22/14 |
Thomas King
BRD | Director/Board Member | 69 | 29/23/29 |
Cindy Jacobs
PSD | President | 66 | 01/08/01 |
1st Jan change | Capi. | |
---|---|---|
+25.69% | 47.9B | |
+46.90% | 41.42B | |
-3.46% | 40.7B | |
-6.20% | 28.92B | |
+9.17% | 25.55B | |
-20.42% | 19.27B | |
+0.17% | 12.15B | |
+28.07% | 12.14B | |
-1.24% | 11.99B |